Morgan Stanley


Morgan Stanley Weighs in on Gilead Sciences, Inc. (GILD) Following Colorado’s Hepatitis C Policy Change

The state of Colorado has just announced it will be loosening restrictions for Medicaid Hepatitis C patients, which could translate to an increase …

Morgan Stanley Previews General Electric Company (GE) Ahead of 3Q:16

Morgan Stanley analyst Nigel Coe provides commentary on shares of General Electric Company (NYSE:GE) ahead of the company’s third quarter results on October …

Morgan Stanley Raises Estimates and Price Target on Micron Technology, Inc. (MU) Following Continued Strength in Commodity Pricing

Following Micron Technology, Inc. (NASDAQ:MU) rallying with a consistently strong performance in memory, Morgan Stanley analyst Joseph Moore remains bullish on the chip …

Morgan Stanley Bullish on Fitbit Inc (FIT) Following New Product Launches

Fitbit Inc (NYSE:FIT) launched upgraded products today, Flex 2 and Charge 2, accompanied by new accessories, coupled with new software features for existing …

Morgan Stanley Chimes in on Celgene Corporation (CELG) Ahead of GED-0301 Topline Data

Morgan Stanley analyst Matthew Harrison provides commentary on Celgene Corporation (NASDAQ:CELG) ahead of topline data due for its pipeline oral Crohn’s drug GED-0301 …

Morgan Stanley Weighs In on Valeant Pharmaceuticals Intl Inc (VRX) and Amgen, Inc. (AMGN) Following Headquarter Visit and FDA CRL

Morgan Stanley analysts were out today with commentary on healthcare giants Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Amgen, Inc. (NASDAQ:AMGN).

Morgan Stanley Chimes In On Two Healthcare Giants: Valeant Pharmaceuticals Intl Inc (VRX), Biogen Inc (BIIB)

Healthcare analysts are weighing in on healthcare giants Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Biogen Inc (NASDAQ:BIIB). While one analyst becomes more bullish on Valeant as …

Morgan Stanley Weighs in on QUALCOMM, Inc. (QCOM) Following ‘Earnings Power Analysis’ Update

Morgan Stanley reduces peak earnings estimate for QUALCOMM to $6.28 from $6.

Morgan Stanley Bullish On Palo Alto Networks Inc (PANW) Ahead Of FQ4:16

Palo Alto Networks Inc (NYSE:PANW) entered its fiscal fourth-quarter “against very low expectations,” in the eyes of Morgan Stanley analyst Keith Weiss. Yet, …

Top Analyst’s Take on Cypress Semiconductor Corporation (CY) as CEO Transition Unfolds

Morgan Stanley top analyst Craig Hettenbach reiterates an Equal Weight rating on Cypress Semiconductor Corporation (NASDAQ:CY), as the company selected its second CEO in a long history of 34 …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts